K2 Oncology is a R&D high tech Biotech Corp with its headquarter in Beijing, China. The company focus on novel tumor organoids cell culture technology. Based on patented ViaCyte cancer organoids culture platform, K2 Oncology has established unique 3-D culture systems similar to in vivo micro-environments. K2 Oncology can offer >2500 tumor organoids model collections for cancer research and therapeutic drug discovery.
K2 Oncology has not received any reviews.
K2 Oncology has not received any endorsements.